Robert A. de Man

20.3k citations
335 papers · 12.8k · 1 hit paper · h-index 61

Impact in

  • Hepatology top 0.05%
    • Hepatitis C virus research
    • Hepatitis Viruses Studies and Epidemiology
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Liver Disease and Transplantation
  • Epidemiology top 0.1%
    • Hepatitis B Virus Studies
    • Liver Disease Diagnosis and Treatment

Papers in

    • Hepatitis C virus research 93
    • Hepatocellular Carcinoma Treatment and Prognosis 58
    • Hepatitis Viruses Studies and Epidemiology 48
    • Liver Disease and Transplantation 29
    • Liver Diseases and Immunity 17
    • Hepatitis B Virus Studies 139
    • Liver Disease Diagnosis and Treatment 69

Robert A. de Man

325 papers receiving 12.4k citations

Robert A. de Man's Hit Papers

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial 2005 · 866 citations
8660+7+14Years since publication250500750

Peers

Robert A. de Man
Comparison fields: 5 of 157
  • Hepatology 7.1k
  • Epidemiology 6.9k
  • Infectious Diseases 1.2k
  • Surgery 1.3k
  • Pharmacology 277
Replace Antonio Craxı̀ with:
Antonio Craxı̀ Italy
Christoph Sarrazin Germany
Myron J. Tong United States
Ansgar W. Lohse Germany
Françoise Roudot‐Thoraval France
Daniel Dhumeaux France
Jenny Heathcote Canada
Graham R. Foster United Kingdom
Harry L.A. Janssen Netherlands
A. Albertí Italy
Robert A. de Man relative to Antonio Craxı̀ Italy Antonio Craxı̀'s profile →
Citations per field
00.5×1.5×
Antonio Craxı̀ · 1×
Citations per year

Countries citing papers authored by Robert A. de Man

Since Specialization
Citations

This map shows the geographic impact of Robert A. de Man's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. de Man with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. de Man more than expected).

Fields of papers citing papers by Robert A. de Man

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. de Man. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. de Man. The network helps show where Robert A. de Man may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert A. de Man, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert A. de Man Line = papers co-authored together Robert A. de Man links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 335 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
Hit paper breakdown →
2005866
2 1992329
3 2007283
4 2009264
5 2004252
6 1998238
7
Hallux valgus-etiology, anatomy, treatment and surgical considerations
1981214
8 2003203
9 2006197
10 2009189
11 2000181
12 2020175
13 2000174
14 2000169
15 2011159
16 2013150
17 2007147
18 2019138
19 2015129
20 2001126

About Robert A. de Man

Robert A. de Man is a scholar working on Hepatology, Epidemiology, Surgery, Infectious Diseases and Immunology, having authored 335 papers that have together received 12.8k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (139 papers), Hepatitis C virus research (93 papers), Liver Disease Diagnosis and Treatment (69 papers), Hepatocellular Carcinoma Treatment and Prognosis (58 papers), Hepatitis Viruses Studies and Epidemiology (48 papers), Liver Disease and Transplantation (29 papers), Liver Diseases and Immunity (17 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers). The work is most often cited by research in Hepatology (7.1k citations), Epidemiology (6.9k citations), Infectious Diseases (1.2k citations), Surgery (1.3k citations) and Pharmacology (277 citations). Robert A. de Man has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Solko W. Schalm, Harry L.A. Janssen, Hubert G.M. Niesters, Jan N.M. IJzermans, Bettina E. Hansen, Pieter E. Zondervan, Monika van Zonneveld, Suzan D. Pas, Pieter Honkoop and Türkan Terkivatan. Their work appears in journals such as Journal of Hepatology, Journal of Viral Hepatitis, European Journal of Gastroenterology & Hepatology, Hepatology and Liver International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact